缺乏葡萄糖驱动了依赖LIF的肺癌
Fedra Luciano-Mateo1, Joaquim Moreno-Caceres1, Miguel Hernández-Madrigal1
1Preclinical and Experimental Research in Thoracic Tumors (PRETT Group), Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
在缺乏葡萄糖的情况下,癌细胞释放LIF,一种促进瘤生长的细胞因子. 曼诺斯补充剂和向LIF显示了抗癌疗法的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
背景情况:
- 葡萄糖缺乏和缺氧会触发细胞因子分泌,以调节免疫系统和血液流动.
- 白血病抑制因子 (LIF) 是一种参与固体瘤发育的干白素-6家族细胞因子.
研究的目的:
- 研究葡萄糖剥夺和缺氧在癌细胞LIF分泌中的作用.
- 探索针对非小细胞肺癌 (NSCLC) 的LIF治疗潜力.
主要方法:
- 在各种代谢条件下分析癌细胞的细胞因子分泌.
- 使用NSCLC小鼠模型来评估LIF减少的影响.
- 在NSCLC患者中,与临床标志物相关联的LIF水平.
主要成果:
- 癌细胞在缺乏葡萄糖或缺氧的情况下,与其他代谢压力因素不同,分泌LIF.
- 曼诺斯补充剂通过维持代谢途径来防止LIF释放.
- 在NSCLC小鼠模型中,LIF的减少抑制了瘤生长,血管生成和转移,同时促进了抗瘤免疫反应.
- 在NSCLC患者中LIF水平升高与缺氧,葡萄糖缺乏和血管生成标志物相关.
结论:
- LIF是一种关键的细胞因子,由癌细胞的代谢压力 (葡萄糖缺乏,缺氧) 诱导.
- 准LIF是一种潜在的治疗策略,可以破坏癌症的适应反应.
- 抑制LIF可以损害瘤的进展,并调节瘤的免疫微环境.
更多相关视频
08:56Oxygen-Glucose Deprivation and Reoxygenation as an In Vitro Ischemia-Reperfusion Injury Model for Studying Blood-Brain Barrier Dysfunction
Published on: May 7, 2015
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
相关概念视频
Lung Capacity
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
